Cargando…
DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
INTRODUCTION: Current chemotherapy protocols for treatment of embryonal brain tumors in infants recommend administration of intrathecal chemotherapy either by a lumbar tap or via an Ommaya reservoir. Children with concurrent hydrocephalus and shunts may have sub-therapeutic levels of chemotherapy in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164974/ http://dx.doi.org/10.1093/neuonc/noac079.124 |
_version_ | 1784720275339739136 |
---|---|
author | Dvir, Rina Rosenberg, Tom Elhasid, Ronit Levin, Dror Constantini, Shlomi Roth, Jonathan |
author_facet | Dvir, Rina Rosenberg, Tom Elhasid, Ronit Levin, Dror Constantini, Shlomi Roth, Jonathan |
author_sort | Dvir, Rina |
collection | PubMed |
description | INTRODUCTION: Current chemotherapy protocols for treatment of embryonal brain tumors in infants recommend administration of intrathecal chemotherapy either by a lumbar tap or via an Ommaya reservoir. Children with concurrent hydrocephalus and shunts may have sub-therapeutic levels of chemotherapy in the CSF due to constant CSF drainage to extra-CNS compartments. We present our experience in delivery of chemotherapy to young children via programmable valves. RESULTS: A retrospective analysis of infants with CNS malignancies and hydrocephalus treated with a shunt and a programmable valve (CERTAS™ Plus Programmable Valves - Integra Life Sciences) was conducted. Five infants 1.1-3 years of age (mean 2) were included. Pathologies included atypical teratoid rhabdoid tumor (ATRT N=2), medulloblastoma (N=2), and metastatic rhabdomyosarcoma(N=1). Intrathecal injections were conducted in an outpatient setting unless hospitalization was required for other reasons. Only one child required sedation due to noncompliance. A total of 61 chemotherapeutic administrations were performed directly through the valve while set on an extremely high opening pressure for several hours( 35 with hydrocortisone and cytarabine, 26 with topotecan). There were no infections, leaks or major complications. One child required a wound revision due to exposure of the proximal catheter related to extremely thin skin, one child developed somnolence and fever which were not related to a shunt malfunction or infection, and one child had clinical and radiological shunt over-drainage solved by increasing of valve settings. CONCLUSIONS: Programmable ventriculoperitoneal valves appear to a safe method for delivery of chemotherapy in infants with malignant CNS tumors .This technique may potentially have an added value for children with concurrent shunts, and may also obviate the need for an additional ventricular access device . |
format | Online Article Text |
id | pubmed-9164974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91649742022-06-05 DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. Dvir, Rina Rosenberg, Tom Elhasid, Ronit Levin, Dror Constantini, Shlomi Roth, Jonathan Neuro Oncol Drug Delivery/Pharmacokinetics INTRODUCTION: Current chemotherapy protocols for treatment of embryonal brain tumors in infants recommend administration of intrathecal chemotherapy either by a lumbar tap or via an Ommaya reservoir. Children with concurrent hydrocephalus and shunts may have sub-therapeutic levels of chemotherapy in the CSF due to constant CSF drainage to extra-CNS compartments. We present our experience in delivery of chemotherapy to young children via programmable valves. RESULTS: A retrospective analysis of infants with CNS malignancies and hydrocephalus treated with a shunt and a programmable valve (CERTAS™ Plus Programmable Valves - Integra Life Sciences) was conducted. Five infants 1.1-3 years of age (mean 2) were included. Pathologies included atypical teratoid rhabdoid tumor (ATRT N=2), medulloblastoma (N=2), and metastatic rhabdomyosarcoma(N=1). Intrathecal injections were conducted in an outpatient setting unless hospitalization was required for other reasons. Only one child required sedation due to noncompliance. A total of 61 chemotherapeutic administrations were performed directly through the valve while set on an extremely high opening pressure for several hours( 35 with hydrocortisone and cytarabine, 26 with topotecan). There were no infections, leaks or major complications. One child required a wound revision due to exposure of the proximal catheter related to extremely thin skin, one child developed somnolence and fever which were not related to a shunt malfunction or infection, and one child had clinical and radiological shunt over-drainage solved by increasing of valve settings. CONCLUSIONS: Programmable ventriculoperitoneal valves appear to a safe method for delivery of chemotherapy in infants with malignant CNS tumors .This technique may potentially have an added value for children with concurrent shunts, and may also obviate the need for an additional ventricular access device . Oxford University Press 2022-06-03 /pmc/articles/PMC9164974/ http://dx.doi.org/10.1093/neuonc/noac079.124 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Drug Delivery/Pharmacokinetics Dvir, Rina Rosenberg, Tom Elhasid, Ronit Levin, Dror Constantini, Shlomi Roth, Jonathan DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. |
title | DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. |
title_full | DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. |
title_fullStr | DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. |
title_full_unstemmed | DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. |
title_short | DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. |
title_sort | ddel-03. the use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with cns tumors and hydrocephalus. |
topic | Drug Delivery/Pharmacokinetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164974/ http://dx.doi.org/10.1093/neuonc/noac079.124 |
work_keys_str_mv | AT dvirrina ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus AT rosenbergtom ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus AT elhasidronit ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus AT levindror ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus AT constantinishlomi ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus AT rothjonathan ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus |